Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
ViroPharma And Generic Vancocin: A Contentious IssueTheodore Cohen • Wed, Apr 11, 2012
-
-
Something to Like About ViroPharma: Management Stock OwnershipNakedValue • Sun, Apr 24, 2011 -
-
ViroPharma Finally Able to Look ForwardEP Vantage • Thu, Aug 6, 2009 -
-
-
-
Viropharma's Antiviral Bombs: Here We Go AgainDerek Lowe • Tue, Feb 10, 2009 -
-
-
-
-
-
-
ViroPharma: Still ImpressiveHilary Kramer • Tue, Apr 3, 2007
To learn more about Seeking Alpha Pro, click here.
-
-
-
The Upward Climb Of Halozyme TherapeuticsJohn Eastman • Mon, Jan 14 -
Halozyme Therapeutics Set To Shine On Deal With PfizerPropThink • Fri, Dec 21, 2012
-
Dyax And ViroPharma: An Overview Of HAE SpaceLifeSci Advisors • Tue, Sep 18, 2012 -
-
-
-
-
-
-
6 Analyst Backed Small Cap Biotech Stocks With Plenty Of Cash CashZetaKap • Fri, Aug 3, 2012
-
-
-
-
-
-
3 Cash-Hoarding Biotech Stocks With Solid ProfitsZetaKap • Wed, Jul 4, 2012
-
-
-
ViroPharma Management Discusses Q3 2012 Results - Earnings Call TranscriptFri, Oct 26, 2012 • 2 Comments
-
ViroPharma's CEO Discusses Q2 2012 Results - Earnings Call TranscriptFri, Aug 10, 2012
-
ViroPharma Incorporated Q3 2009 Earnings Call TranscriptWed, Oct 28, 2009
-
ViroPharma Incorporated Q1 2009 Earnings Call TranscriptWed, Apr 29, 2009
-
ViroPharma, Inc., Q4 2008 Earnings Call TranscriptTue, Feb 24, 2009
-
ViroPharma Incorporated Q3 2008 Earnings Call TranscriptWed, Oct 29, 2008
-
ViroPharma Incorporated Q2 2008 Earnings Call TranscriptMon, Aug 25, 2008
-
ViroPharma Incorporated Q1 2008 Earnings Call TranscriptWed, May 28, 2008
-
ViroPharma Incorporated Q4 2007 Earnings Call TranscriptMon, Mar 10, 2008
-
PR Newswire (Jun 11, 2013)
-
PR Newswire (May 31, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (Apr 25, 2013)
-
at CNBC.com (Apr 17, 2013)
-
at CNBC.com (Apr 16, 2013)
-
at CNBC.com (Mar 8, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 22, 2013)
-
PR Newswire (Feb 11, 2013)
-
at MarketWatch.com (Jan 15, 2013)
-
PR Newswire (Jan 7, 2013)
-
PR Newswire (Dec 12, 2012)
-
PR Newswire (Nov 29, 2012)
-
PR Newswire (Nov 8, 2012)
VPHM vs. ETF Alternatives
Company Description
ViroPharma Incorporated and subsidiaries is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. We have two marketed products and two... More
